Mouloudi, E <br/><br/>
Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.  [electronic resource] 

 -  Transplantation proceedings  Nov 2014 
 - 3219-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1873-2623 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2014.09.160  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--therapeutic use<br/>Carbapenems--pharmacology<br/>Female<br/>Follow-Up Studies<br/>Greece--epidemiology<br/>Humans<br/>Incidence<br/>Intensive Care Units<br/>Klebsiella Infections--drug therapy<br/>Klebsiella pneumoniae--drug effects<br/>Liver Transplantation<br/>Male<br/>Middle Aged<br/>Minocycline--analogs & derivatives<br/>Pilot Projects<br/>Prospective Studies<br/>Risk Factors<br/>Tigecycline<br/>Time Factors<br/>Treatment Outcome<br/>beta-Lactam Resistance